Adolescents experience a significant burden of mental health disorders, with trends indicating rising prevalence across several conditions.  Anxiety disorders, particularly generalized anxiety disorder and social anxiety disorder, and depressive disorders, encompassing major depressive disorder and persistent depressive disorder, represent a substantial portion of this burden.  Furthermore, the increasing prevalence of substance use disorders, often comorbid with other mental health issues, poses a significant challenge.  These trends are influenced by complex interplay of factors, including genetic predisposition, societal pressures, exposure to trauma, and evolving digital landscapes.  Treatment approaches vary depending on the specific diagnosis and severity, ranging from evidence-based psychotherapies such as Cognitive Behavioral Therapy (CBT) and Dialectical Behavior Therapy (DBT) to pharmacological interventions including selective serotonin reuptake inhibitors (SSRIs) and other antidepressants.  Integrated approaches, combining psychotherapy with medication management, often yield the most positive outcomes.  Early identification and timely intervention are crucial for improving long-term prognosis, minimizing the impact of these disorders on academic achievement, social functioning, and overall well-being.  Further research is needed to address specific vulnerabilities within adolescent populations and to refine existing interventions for optimal efficacy and accessibility.